Results 1 to 20 of 77
Page 1 of 4  Next >
TypeTitleAuthor(s)YearViews
Efficacy and safety of single agent sunitinib in treating sorafenib refractory advanced hepatocellular carcinoma patients: a prospective, open-label, phase II studyYau, TCC; Leung, RCY; Wong, HYH; Chiu, JWY; Chan, P; Tang, YF; Cheung, TT; Pang, RWC; Fan, ST; Poon, RTP201363
 
A multicenter phase II study of sorafenib, capecitabine, and oxaliplatin (SECOX) in patients with advanced hepatocellular carcinoma: final results of Hong Kong-Singapore Hepatocellular Carcinoma Research Collaborative Group studyYau, TCC; Cheung, FY; Lee, F; Choo, SP; Wong, HYH; Toh, HC; Leung, AK; Chan, P; Yau, TK; Wong, J; Tang, YF; Lau, JSM; Cheung, TT; Fan, ST; Poon, RTP201359
 
Mapping the functional assessment of cancer therapy-general or -colorectal to SF-6D in Chinese patients with colorectal neoplasmWong, CKH; Lam, CLK; Rowen, D; McGhee, SM; Ma, KP; Law, WL; Poon, JTC; Chan, P; Kwong, DLW; Tsang, J2012316
 
Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspectiveWong, CKH; Lam, CLK; Poon, JTC; Mcghee, SM; Law, WL; Kwong, DLW; Tsang, J; Chan, P2012450
 
The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: A retrospective analysis of efficacy, safety, and survival benefitsChiu, J; Tang, YF; Yao, TJ; Wong, A; Wong, H; Leung, R; Chan, P; Cheung, TT; Chan, AC; Pang, R; Fan, ST; Poon, R; Yau, T2012126
 
Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasmWong, CKH; Lam, CLK; Law, WL; Poon, JTC; Chan, P; Kwong, DLW; Tsang, J2012375
 
Colon cancer in a patient with underlying aplastic anemia: A clinical challengeWong, H; Chan, P; Yau, TCC201261
 
Being active or flexible? Role of control coping on quality of life among patients with gastrointestinal cancerCheng, C; Chan, NY; Chio, JHM; Chan, P; Chan, AOO; Hui, WM2012135
 
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory diseaseYau, T; Wong, H; Chan, P; Yao, TJ; Pang, R; Cheung, TT; Fan, ST; Poon, RT2012119
 
The cardioprotective effect of isosteviol on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytesWong, KL; Chao, CC; Cheung, CW; Chan, P; Cheng, TH; Leung, YM201258
 
Combination of bevacizumab and erlotinib in the treatment of patients with advanced hepatocellular carcinoma with sorafenib-refractory disease: results of a pilot phase II studyYau, T; Wong, H; Chan, P; Yao, T; Cheung, TT; Fan, ST; Poon, RTP201224
 
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinomaYau, T; Cheng, PN; Chan, P; Chan, W; Chen, L; Yuen, J; Pang, R; Fan, ST; Poon, RT2012147
 
Phase I dose-finding study of pazopanib in hepatocellular carcinoma: Evaluation of early efficacy, pharmacokinetics, and pharmacodynamicsYau, T; Chen, PJ; Chan, P; Curtis, CM; Murphy, PS; Suttle, AB; Gauvin, J; Hodge, JP; Dar, MM; Poon, RT2011210
 
Cost-effectiveness analysis of colorectal cancer screening in Hong KongWong, KH; Lam, CLK; Law, WL; Poon, JTC; Chan, P; McGhee, S; Fong, DYT; Kwong, DLW; Tsang, JWH2011147
 
The use of single-agent sorafenib in the treatment of patients with advanced hepatocellular carcinoma with underlying Child-Pugh B liver cirrhosisChiu, J; Tang, YF; Yao, TJ; Wong, A; Wong, H; Leung, R; Chan, P; Cheung, TT; Poon, RTP; Fan, ST; Yau, CC2011200
 
The outcomes of elderly patients with advanced hepatocellular carcinoma treated with single agent Sorafenib (Abstract)Chan, P; Wong, H; Yao, TJ; Tang, VWK; Wong, H; Fan, ST; Poon, RTP; Yau, TCC2011121
 
Mapping the functional assessment of cancer therapy-general or -colorectal to preference-based values measured by SF-6D in patients with colorectal neoplasmWong, CKH; Lam, CLK; McGhee, SM; Law, WL; Poon, TCJ; Chan, P; Kwong, DLW; Tsang, J; Rowen, DL2011122
 
Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: A randomized controlled trialTan, VPY; Wong, WM; Cheung, TK; Lai, KC; Hung, IFN; Chan, P; Pang, R; Wong, BCY2011214
 
Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: a prospective, open-label, phase II studyYau, T; Leung, RC; Wong, H; Chiu, J; Chan, P; Pang, R; Fan, ST; Poon, RTP2011198
 
Efficacy and safety of single-agent sunitinib in treating advanced hepatocelluar carcinoma patients after sorafenib failure: a prospective, open-label, phase II study (Abstract)Yau, TCC; Leung, RCY; Wong, H; Chiu, J; Chan, P; Pang, RWC; Fan, ST; Poon, RTP2011190
 
Page 1 of 4  Next >
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download